The significance of a single episode of minimal acute rejection after lung transplantation

被引:132
|
作者
Hachem, RR
Khalifah, AP
Chakinala, MM
Yusen, RD
Aloush, AA
Mohanakumar, T
Patterson, GA
Trulock, EP
Walter, MJ
机构
[1] Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO 63110 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75230 USA
[3] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA
关键词
lung transplantation; minimal acute rejection; bronchiolitis obliterans syndrome;
D O I
10.1097/01.tp.0000181161.60638.fa
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Bronchiolitis obliterans syndrome (BOS) remains the leading obstacle to better long-term outcomes after lung transplantation. Acute rejection has been identified as the primary risk factor for BOS, but the impact of minimal acute rejection, especially a solitary episode, has usually been discounted as clinically insignificant. Methods. We performed a retrospective cohort study of 259 adult lung transplant recipients to determine the risk of BOS associated with a single episode of A1 rejection, without recurrence or subsequent progression to a higher grade. The cohort was divided into 3 groups based on the severity of acute rejection (none, single episode of A1, and single episode of A2). We determined the risks of BOS stages 1, 2, 3, and death for each group using univariate and multivariate Cox regression analyses. Results. A solitary episode of At rejection was a significant risk factor for BOS stages I and 2, but not stage 3 or death, in the univariate analysis. Multivariate Cox regression models confirmed that the risk of BOS attributable to a single episode of A1 rejection was independent of other potential risk factors, such as community acquired respiratory viral infections, number of HLA mismatches, and cytomegalovirus pneumonitis. Likewise, univariate and multivariate analyses demonstrated that a single episode of A2 rejection was a significant risk factor for all stages of BOS but not death. Conclusions. A single episode of minimal acute rejection without recurrence or subsequent progression to a higher grade is a significant predictor of BOS independent of other risk factors.
引用
收藏
页码:1406 / 1413
页数:8
相关论文
共 50 条
  • [41] Ineffective esophageal motility is associated with acute rejection after lung transplantation independent of gastroesophageal reflux
    Lo, Wai-Kit
    Hiramoto, Brent
    Goldberg, Hilary J.
    Sharma, Nirmal
    Chan, Walter W.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (21) : 3292 - 3301
  • [42] The Amide Local Anesthetic Ropivacaine Attenuates Acute Rejection After Allogeneic Mouse Lung Transplantation
    Tatsuo Maeyashiki
    Jae-Hwi Jang
    Florian Janker
    Yoshito Yamada
    Ilhan Inci
    Walter Weder
    Tobias Piegeler
    Wolfgang Jungraithmayr
    Lung, 2019, 197 : 217 - 226
  • [43] The Amide Local Anesthetic Ropivacaine Attenuates Acute Rejection After Allogeneic Mouse Lung Transplantation
    Maeyashiki, Tatsuo
    Jang, Jae-Hwi
    Janker, Florian
    Yamada, Yoshito
    Inci, Ilhan
    Weder, Walter
    Piegeler, Tobias
    Jungraithmayr, Wolfgang
    LUNG, 2019, 197 (02) : 217 - 226
  • [44] Rabbit Antithymocyte Globulin for Treatment of Corticosteroid Refractory Acute Cellular Rejection After Lung Transplantation
    Rudzik, Katelyn N.
    Moore, Cody A.
    Sacha, Lauren M.
    Rivosecchi, Ryan M.
    Saul, Melissa
    Pilewski, Joseph M.
    Kilaru, Silpa D.
    Snyder, Mark E.
    McDyer, John F.
    Iasella, Carlo J.
    TRANSPLANTATION, 2023, 107 (08) : 1828 - 1834
  • [45] Pattern and predictors of early rejection after lung transplantation
    Dabbs, AD
    Hoffman, LA
    Iacono, AT
    Wells, CL
    Grgurich, W
    Zullo, TG
    McCurry, KR
    Dauber, JH
    AMERICAN JOURNAL OF CRITICAL CARE, 2003, 12 (06) : 497 - 507
  • [46] Acute Fibrinoid Organizing Pneumonia after Lung Transplantation
    Paraskeva, Miranda
    McLean, Catriona
    Ellis, Samantha
    Bailey, Michael
    Williams, Trevor
    Levvey, Bronwyn
    Snell, Gregory I.
    Westall, Glen P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (12) : 1360 - 1368
  • [47] Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation
    Ensor, Christopher R.
    Rihtarchik, Lindsey C.
    Morrell, Matthew R.
    Hayanga, J. W. Awori
    Lichvar, Alicia B.
    Pilewski, Joseph M.
    Wisniewski, Stephen
    Johnson, Bruce A.
    D'Cunha, Jonathan
    Zeevi, Adriana
    McDyer, John F.
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [48] A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
    Vos, R.
    Vanaudenaerde, B. M.
    Verleden, S. E.
    De Vleeschauwer, S. I.
    Willems-Widyastuti, A.
    Van Raemdonck, D. E.
    Schoonis, A.
    Nawrot, T. S.
    Dupont, L. J.
    Verleden, G. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (01) : 164 - 172
  • [49] Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart/lung transplantation
    Sleiman, C
    Groussard, O
    Mal, H
    Fournier, M
    REVUE DES MALADIES RESPIRATOIRES, 1996, 13 (05) : S31 - S40
  • [50] Vancomycin lung concentration in acute and hyperacute rejection models of lung transplantation in rats
    Pierog, Jaroslaw
    Kubisa, Bartosz
    Drozdzik, Marek
    Wojcik, Janusz
    Bielewicz, Michat
    Pankowski, Juliusz
    Safranow, Krzysztof
    Grodzki, Tomasz
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 38 (04) : 456 - 460